Headquarters
681 GATEWAY BLVD, 4TH FLOOR, SOUTH SAN FRANCISCO, CA 94080-7015, US
SOUTH SAN FRANCISCO, CA, US
IGGENIX, INC.
From the company
IgGenix, Inc. is a clinical-stage antibody discovery and development company with a mission to solve allergies and other immunological diseases. Using its SEQ SIFTER™ single cell RNA-sequencing-based discovery platform, it captures rare human B cells that produce IgE antibodies from human blood and re-engineers fully human, high-affinity, allergen-specific IgG antibodies designed to block the allergic cascade. Its lead candidate IGNX001 targets peanut allergy and has completed a Phase 1 clinical trial.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.